Nephros (NEPH) Share-based Compensation (2010 - 2026)
Nephros (NEPH) posted Share-based Compensation of $346000.0 for Q2 2026, down 14.99% on a QoQ basis from $407000.0 in Q1 2026, and down 28.07% year-over-year from $481000.0 in Q2 2025.
Powered by 
Analysis
Nephros (NEPH) Share-based Compensation (2010 - 2026) Analysis & Trends
Nephros has reported Share-based Compensation for 17 years, with the latest figure at $346000.0 in Q2 2026.
- On a quarterly basis, Share-based Compensation fell 28.07% year-over-year to $346000.0 in Q2 2026; TTM through Jun 2026 was $346000.0, a 28.07% decrease from a year earlier, with the FY2025 full-year figure at $1.3 billion, up 101905.18% from the prior year.
- Share-based Compensation was $346000.0 for Q2 2026 at Nephros, down from $407000.0 in the prior quarter.
- The five-year high for Share-based Compensation was $2.1 million in Q2 2022, with the low at -$11000.0 in Q1 2024.
- Average Share-based Compensation over 5 years is $531444.4, with a median of $429000.0 recorded in 2025.
- The sharpest annual moves came in 2022 and 2024: Share-based Compensation jumped 876.74% in 2022, then plunged 103.45% in 2024.
- Over 5 years, Share-based Compensation stood at $179000.0 in 2022, then surged by 180.45% to $502000.0 in 2023, then sank by 87.65% to $62000.0 in 2024, then surged by 33.87% to $83000.0 in 2025, then surged by 316.87% to $346000.0 in 2026.
- The last three Share-based Compensation figures came in at $346000.0 (Q2 2026), $407000.0 (Q1 2026), and $83000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | 67.10 Mn |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | 125.00 Mn |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | 7.00 Mn |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | 61.00 Mn |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | 42.20 Mn |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | 42.00 Mn |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | 39.00 Mn |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | 12.80 Mn |
| 10 | Nephros | 48.31 Mn | 43.62 Mn | 4.03 Mn | 346,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 346,000.00 |
| Mar 31, 2026 | 407,000.00 |
| Dec 31, 2025 | 83,000.00 |
| Sep 30, 2025 | 451,000.00 |
| Jun 30, 2025 | 481,000.00 |
| Mar 31, 2025 | 76,000.00 |
| Dec 31, 2024 | 62,000.00 |
| Sep 30, 2024 | 555,000.00 |
| Jun 30, 2024 | 625,000.00 |
| Mar 31, 2024 | -11,000.00 |
| Dec 31, 2023 | 502,000.00 |
| Sep 30, 2023 | 819,000.00 |
| Jun 30, 2023 | 1.00 Mn |
| Mar 31, 2023 | 319,000.00 |
| Dec 31, 2022 | 179,000.00 |
| Sep 30, 2022 | 1.30 Mn |
| Jun 30, 2022 | 2.10 Mn |
| Mar 31, 2022 | 272,000.00 |
| Dec 31, 2021 | 434,000.00 |
| Sep 30, 2021 | 212,000.00 |